Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « ISSN » - entrée « 1529-8019 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1529-7535 < 1529-8019 < 1530-0293  Facettes :

List of bibliographic references indexed by 1529-8019

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000109 (2021) Hailey Olds [États-Unis] ; Jesse Liu [États-Unis] ; Kevin Luk [États-Unis] ; Henry W. Lim [États-Unis] ; David Ozog [États-Unis] ; Pranita V. Rambhatla [États-Unis]Telogen effluvium associated with COVID-19 infection.
000497 (2021) I N Nur Sultan Öncü [Turquie] ; Dilara Güler [Turquie] ; Gülhan Gürel [Turquie]Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.
000759 (2021) Niloufar Najar Nobari [Iran] ; Farnoosh Seirafianpour [Iran] ; Farzaneh Mashayekhi [Iran] ; Azadeh Goodarzi [Iran]A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
000A49 (2020) Jelena Stojkovic-Filipovic [Serbie] ; Martina Bosic [Serbie]Treatment of COVID 19-Repurposing drugs commonly used in dermatology.
000B10 (2020) Monica Shah [Canada] ; Muskaan Sachdeva [Canada] ; Roni P. Dodiuk-Gad [Canada, Israël]The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
001148 (2020) James T. Pathoulas [États-Unis] ; Kelly E. Flanagan [États-Unis] ; Chloe J. Walker [États-Unis] ; Isabel M. Pupo Wiss [États-Unis] ; Dina Hagigeorges [États-Unis] ; Maryanne M. Senna [États-Unis]Hydroxychloroquine use and COVID-19 concerns among alopecia patients: A cross-sectional survey study.
001193 (2020) Satarupa Kumar [Inde] ; Abheek Sil [Inde] ; Anupam Das [Inde]Hydroxychloroquine for COVID-19: Myths vs facts.
001278 (2020) Robert A. Schwartz [États-Unis] ; Camila K. Janniger [États-Unis]Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
001398 (2020) Mauro Grandolfo [Italie] ; Paolo Romita [Italie] ; Domenico Bonamonte [Italie] ; Gerardo Cazzato [Italie] ; Katharina Hansel [Italie] ; Luca Stingeni [Italie] ; Claudio Conforti [Italie] ; Roberta Giuffrida [Italie] ; Caterina Foti [Italie]Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
001431 (2020) Mansak Shishak [Inde] ; Rashmi Sarkar [Inde]Dermatological therapies with relevance to COVID-19.
001445 (2020) Ümit Türsen [Turquie] ; Belma Türsen [Turquie] ; Torello Lotti [Italie]Cutaneous sıde-effects of the potential COVID-19 drugs.
001472 (2020) Resat Ozaras [Turquie] ; Ahmet Berk [Turquie] ; Dilek Hasman Ucar [Turquie] ; Habibe Duman [Turquie] ; Fatma Kaya [Turquie] ; Huseyin Mutlu [Turquie]Covid-19 and exacerbation of psoriasis.
001542 (2020) Ana Suarez-Valle [Espagne] ; Diego Fernandez-Nieto [Espagne] ; Ana Melian-Olivera [Espagne] ; Miguel Dominguez-Santas [Espagne] ; Borja Diaz-Guimaraens [Espagne] ; Carmen M. Garcia Del Real [Espagne] ; Juan Jimenez-Cauhe [Espagne]Comment on "Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine": Report of a COVID-19 patient with particular findings.
001854 (2020) Robert A. Schwartz [États-Unis] ; Robert M. Suskind [États-Unis]Azithromycin and COVID-19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration.
001925 (2020) Paola Sgubbi [Italie] ; Francesco Savoia [Italie] ; Ombretta Calderoni [Italie] ; Rosita Longo [Italie] ; Caterina Stinchi [Italie] ; Michela Tabanelli [Italie]Alopecia areata in a patient with SARS-Cov-2 infection.
001941 (2020) E. Rossi [Italie] ; C. Lasagni [Italie] ; M. Trakatelli [Grèce] ; S. Wertzberger Rowan [Italie] ; C. Magnoni [Italie]Acute maculopapular eruption in Covid-19 patient: A case report.
001945 (2020) Tyler Enos [États-Unis] ; Haneol S. Jeong [États-Unis] ; Travis Vandergriff [États-Unis] ; Heidi T. Jacobe [États-Unis] ; Benjamin F. Chong [États-Unis]Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
001947 (2020) Noureddine Litaiem [Tunisie] ; Khaoula Hajlaoui [Tunisie] ; Manel Karray [Tunisie] ; Maroua Slouma [Tunisie] ; Faten Zeglaoui [Tunisie]Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
001994 (2020) Ömer Kutlu [Turquie] ; Ahmet Metin [Turquie]A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1529-8019" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1529-8019" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1529-8019
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021